CROT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.174200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.661600E-01
Normal-vs-Stage2
5.399800E-01
Normal-vs-Stage3
6.380000E-01
Normal-vs-Stage4
8.527900E-02
Stage1-vs-Stage2
3.918800E-01
Stage1-vs-Stage3
2.267600E-01
Stage1-vs-Stage4
6.936200E-01
Stage2-vs-Stage3
2.894000E-01
Stage2-vs-Stage4
4.634600E-01
Stage3-vs-Stage4
3.651700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.519800E-01
Normal-vs-AfricanAmerican
3.324600E-01
Normal-vs-Asian
4.771000E-01
Caucasian-vs-AfricanAmerican
3.396600E-01
Caucasian-vs-Asian
4.919200E-01
AfricanAmerican-vs-Asian
6.172400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.301000E-01
Normal-vs-Female
5.111000E-01
Male-vs-Female
9.733000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.952560E-01
Normal-vs-Age(41-60Yrs)
2.633600E-01
Normal-vs-Age(61-80Yrs)
7.782600E-01
Normal-vs-Age(81-100Yrs)
4.283400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.807800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.120000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.238800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.439600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.063400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.013000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.230000E-01
Normal-vs-Daily Drinker
8.652600E-01
Normal-vs-Weekly Drinker
8.388000E-01
Normal-vs-Occasional Drinker
2.732400E-01
Normal-vs-Social Drinker
2.481000E-01
Non Drinker-vs-Daily Drinker
5.759200E-01
Non Drinker-vs-Weekly Drinker
7.079400E-01
Non Drinker-vs-Occasional Drinker
7.408100E-02
Non Drinker-vs-Social Drinker
1.396210E-01
Daily Drinker-vs-Weekly Drinker
9.280600E-01
Daily Drinker-vs-Occasional Drinker
3.644100E-02
Daily Drinker-vs-Social Drinker
9.271800E-02
Weekly Drinker-vs-Occasional Drinker
8.992300E-02
Weekly Drinker-vs-Social Drinker
1.656420E-01
Occasional Drinker-vs-Social Drinker
5.490600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.504500E-02
Normal-vs-Grade 2
5.482300E-03
Normal-vs-Grade 3
1.741120E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.723400E-01
Grade 1-vs-Grade 3
1.827610E-01
Grade 1-vs-Grade 4
2.504500E-02
Grade 2-vs-Grade 3
2.682400E-01
Grade 2-vs-Grade 4
5.482300E-03
Grade 3-vs-Grade 4
1.741120E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.778600E-01
Normal-vs-NonDiabetic
5.335000E-01
Diabetic-vs-NonDiabetic
5.821000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.067200E-01
Normal-vs-NoPancreatitis
5.865000E-01
Pancreatitis-vs-NoPancreatitis
5.776600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.755400E-01
Normal-vs-N1
5.563800E-01
N0-vs-N1
3.070000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.373000E-01
Normal-vs-TP53-NonMutant
4.325400E-01
TP53-Mutant-vs-TP53-NonMutant
8.807400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
